I 118th CONGRESS 1st Session H. R. 427 IN THE HOUSE OF REPRESENTATIVES January 20, 2023 Mr. Latta (for himself, Mrs. Harshbarger , Mr. Aderholt , Mr. Reschenthaler , Ms. Letlow , Mr. Finstad , Mr. Grothman , Mr. Luetkemeyer , Mr. Dunn of Florida , Mr. Bost , Mr. Babin , Mr. Palmer , Mr. Wenstrup , Mr. Ellzey , Mrs. Miller of Illinois , Mr. Smith of New Jersey , Mr. Banks , Mr. Feenstra , Mr. Pfluger , Mr. Biggs , Mr. C. Scott Franklin of Florida , Mr. Weber of Texas , Mr. Walberg , Mr. LaHood , Mr. Jackson of Texas , Mr. Mann , Mr. Balderson , Mr. Rose , Mr. Guest , Mrs. Boebert , Mr. Waltz , Mr. Perry , and Mr. McHenry ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.